Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.45M 1.37M 1.24M 2.33M 157M 2.35M 16.43M 6.33M 80.38M 6.16M 6.03M 259M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.17M 6.79M 6.16M 11.54M 780M 11.65M 81.42M 31.38M 398M 30.52M 29.86M 1.28B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
6 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-.--%-.--%-.--% 3.65K
-0.01%+1.69%+63.50%+117.58% 1,056B
-1.61%-0.71%+48.89%+70.56% 655B
-1.12%-0.45%+19.35%+72.93% 471B
-1.72%-4.25%+37.79%+39.89% 342B
-0.40%+4.12%+22.89%+29.04% 277B
-0.51%-1.05%+12.98%+12.92% 257B
+1.32%+7.75%+55.19%+56.43% 226B
-0.61%+0.48%+34.95%+100.58% 189B
-0.24%-3.21%-27.79%-61.37% 170B
Average +989.60%+0.46%+26.77%+43.86% 364.29B
Weighted average by Cap. -0.45%+0.76%+39.85%+68.92%

Financials

2007 2008
Net sales 23.47M 20.71M 19.59M 17.77M 33.31M 2.25B 33.64M 235M 90.59M 1.15B 88.12M 86.2M 3.7B 25.96M 22.91M 21.68M 19.66M 36.85M 2.49B 37.22M 260M 100M 1.27B 97.48M 95.36M 4.09B
Net income -20.86M -18.41M -17.42M -15.79M -29.61M -2B -29.9M -209M -80.52M -1.02B -78.32M -76.62M -3.29B -4.01M -3.54M -3.34M -3.03M -5.69M -384M -5.74M -40.13M -15.46M -196M -15.04M -14.71M -632M
Net Debt 18.79M 16.58M 15.69M 14.23M 26.68M 1.8B 26.94M 188M 72.54M 921M 70.56M 69.02M 2.96B 6.49M 5.73M 5.42M 4.91M 9.21M 623M 9.3M 64.99M 25.05M 318M 24.36M 23.83M 1.02B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock